To further corroborate the reduction of metastatic features of melanoma tumor also in vivo we reported a significant reduction of the pro-metastatic chemokine CXCL1 in the plasma of naproxen-HBTA treated mice as compared with vehicle-treated mice (Figure 5C). This evidence concerns the gene CXCL1 and melanoma.